In a series of tweets, the president addressed an unusual controversy stemming from a speech Thursday that New York Fed President John Williams delivered.Marketsread more
Four members of the House Armed Services Committee, including ranking member Mac Thornberry, R-T.X., said moving forward with the contract was critical to U.S. national...Technologyread more
Companies aren't waiting for the U.S.-China trade war to be resolved, says the head of the world's biggest money manager.Investingread more
George Nader helped arrange a January 2017 meeting in the Seychelles between Erik Prince and the head of Russia's sovereign wealth fund, who reported directly to Vladimir...Politicsread more
"I'm not hearing people blame the Fed as much as they're blaming tariffs," says CNBC's Jim Cramer.US Economyread more
Earlier, Williams said in a speech that "it's better to take preventative measures than to wait for disaster to unfold."The Fedread more
Gold has been on fire this year and some investors think it is poised to do something it has only done twice since World War II.Marketsread more
The University of Michigan's preliminary print on its consumer sentiment index ticked up to 98.4, from 98.2 in June. Economists polled by Refinitiv expected the preliminary...Economyread more
The mega-cap tech stocks that have led much of the record-long bull run have started to lose steam, but investors are still giving them the benefit of the doubt.Marketsread more
Houston, we have liftoff. Fifty years ago, man landed on the moon and McDonald's and a handful of other stocks took off into the stratosphere. Two of them have more fuel in...Trading Nationread more
Amazon's PillPack was informed this week that it will soon be cut off from patient medication data, according to people familiar with the matter.Technologyread more
The U.S. Securities and Exchange Commission on Monday temporarily halted trading in Neuromama, whose shares last traded about $56 over the counter, citing concerns including "potentially manipulative" transactions.
The company, whose website and filings say it runs a search engine based on neural technology, is in talks to license "heavy ion fusion" and sells a line of computing devices, had a market value of about $35 billion as of the stock's last trade on Aug. 5.
Neuromama was valued at $4.73 billion on Jan. 15, 2014, when it had 630.1 million shares outstanding, according to a regulatory filing.
The company has not filed quarterly results since then.
The SEC on Monday also cited the accuracy and adequacy of information on "the identity of the people in charge of the company" as reasons for the halt.
Steven Schwartzbard, chairman of the company's advisory board, said the suspension was in response to pressure from short-sellers.
"We're suffering from a negative side effect caused by our success. That's the only way I can put it," Schwartzbard said in an email to Reuters. "We went public, as virtually all small public companies do, on the over-the-counter market. And everything was fine while the stock sold for $5 or $7.50 a share."
Neuromama's stock had more than quadrupled this year to $56.25 as of its last trade on Aug. 5. The stock's 100-day average volume was 418 shares.
Schwartzbard, who also goes by Vladislav "Steven" Zubkis, also said Neuromama had all intentions to upgrade its listing to Nasdaq.
The company said on Monday it was cooperating with the SEC to ensure the suspension was lifted on Aug. 27.
The SEC previously sued Schwartzbard in 1997 for orchestrating a securities fraud scheme involving boiler-room stock sale techniques.
In 2007, he was sentenced to five years in prison after pleading guilty to charges that he defrauded investors out of $1.8 million in connection with the construction of a storage facility and renovation of a Las Vegas Casino.